Xflh Capital CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
XFLH Capital Corporation announced the signing of a non-binding letter of intent for a proposed business combination with Renogen Biolab Inc., a Canadian health service provider.
NYSE
XFLH Capital Corporation announced that its ordinary shares and rights, previously bundled in units, will commence separate trading on the New York Stock Exchange starting March 9, 2026.
NYSE
XFLH Capital Corporation successfully closed its $100 million initial public offering, outlining its SPAC structure, unit components, and trust account mechanisms for future business combinations.